Regorafenib Phase I Study in Mainland Chinese Patients
Clinical trial NCT02398513 · COMPLETED
Trial details
- NCT number
- NCT02398513
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2015-11-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.